Investigating Multi-cancer Biomarkers and Their Cross-predictability in the Expression Profiles of Multiple Cancer Types

Biomarker Insights

Volumn 4, Issue , 2009, Pages

  Tseng, George C ^a   Cheng, Chunrong ^a   Yu, Yan Ping ^b   Nelson, Joel ^b   Michalopoulos, George ^b   Luo, Jian Hua ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

carcinogenesis; common signature; expression profile; meta analysis; multi cancer biomarker

Indexed keywords

EID: 77956357744     PISSN: None     EISSN: 11772719     Source Type: Journal    
DOI: 10.4137/BMI.S930     Document Type: Article

References (23)

1. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 2000; 100: 57–70.
2. Jemal A., Ward E., Wu X., Martin H.J., McLaughlin C.C., Thun M.J. Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States. Cancer Epidemiol Biomarkers Prev. 2005; 14(3): 590–5.
3. Gleason D.F. Classification of prostatic carcinomas. Cancer Chemother Rep. 1966; 50(3): 125–8.
4. Segal E., Friedman N., Koller D., Regev A. A module map showing conditional activity of expression modules in cancer. Nat Genet. 2004; 36(10): 1090–8.
5. Luo J.H., Ren B., Keryanov S. et al. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology. 2006; 44(4): 1012–24.
6. Yu Y.P., Landsittel D., Jing L. et al. Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol. 2004; 22(14): 2790–9.
7. Bhattacharjee A., Richards W.G., Staunton J. et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA. 2001; 98(24): 13790–5.
8. Stransky N., Vallot C., Reyal F. et al. Regional copy number-independent deregulation of transcription in cancer. Nat Genet. 2006; 38(12): 1386–96
9. Kuo W.P., Liu F., Trimarchi J. et al. A sequence-oriented comparison of gene expression measurements across different hybridization-based technologies. Nat Biotechnol. 2006; 24(7): 832–40.
10. Tibshirani R., Hastie T., Narasimhan B., Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA. 2002; 99(10): 6567–72.
11. Draghici S., Khatri P., Martins R.P., Ostermeier G.C., Krawetz S.A. Global functional profiling of gene expression. Genomics. 2003; 81(2): 98–104.
12. LaTulippe E., Satagopan J., Smith A. et al. Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res. 2002; 62(15): 4499–506.
13. Best C.J., Leiva I.M., Chuaqui R.F. et al. Molecular differentiation of high- and moderate-grade human prostate cancer by cDNA microarray analysis. Diagn Mol Pathol. 2003; 12(2): 63–70.
14. Mehra R., Varambally S., Ding L. et al. Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis. Cancer Res. 2005; 65(24): 11259–64.
15. Ramaswamy S., Ross K.N., Lander E.S., Golub T.R. A molecular signature of metastasis in primary solid tumors. Nat Genet. 2003; 33(1): 49–54.
16. Rhodes D.R., Barrette T.R., Rubin M.A., Ghosh D., Chinnaiyan A.M. Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. Cancer Res. 2002; 62(15): 4427–33.
17. Rubin M.A., Varambally S., Beroukhim R. et al. Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer. Cancer Res. 2004; 64(11): 3814–22.
18. Warnat P., Eils R., Brors B. Cross-platform analysis of cancer microarray data improves gene expression based classification of phenotypes. BMC Bioinformatics. 2005; 6: 265.
19. Deblandre G.A., Marinx O.P., Evans S.S. et al. Expression cloning of an interferon-inducible 17-kDa membrane protein implicated in the control of cell growth. J Biol Chem. 1995; 270(40): 23860–6.
20. Lewin A.R., Reid L.E., McMahon M., Stark G.R., Kerr I.M. Molecular analysis of a human interferon-inducible gene family. Eur J Biochem. 1991; 199(2): 417–23.
21. Foster R., Jahroudi N., Varshney U., Gedamu L. Structure and expression of the human metallothionein-IG gene. Differential promoter activity of two linked metallothionein-I genes in response to heavy metals. J Biol Chem. 1988; 263(23): 11528–35.
22. Tsuji S., Kobayashi H., Uchida Y., Ihara Y., Miyatake T. Molecular cloning of human growth inhibitory factor cDNA and its down-regulation in Alzheimer's disease. Embo J. 1992; 11(13): 4843–50.
23. Schmid K.W., Ellis I.O., Gee J.M. et al. Presence and possible significance of immunocytochemically demonstrable metallothionein overexpression in primary invasive ductal carcinoma of the breast. Virchows Arch A Pathol Anat Histopathol. 1993; 422(2): 153–9.